Literature DB >> 26806484

Natural killer cell memory in infection, inflammation and cancer.

Adelheid Cerwenka1, Lewis L Lanier2.   

Abstract

Immunological memory can be defined as a quantitatively and qualitatively enhanced immune response upon rechallenge. For natural killer (NK) cells, two main types of memory exist. First, similarly to T cells and B cells, NK cells can exert immunological memory after encounters with stimuli such as haptens or viruses, resulting in the generation of antigen-specific memory NK cells. Second, NK cells can remember inflammatory cytokine milieus that imprint long-lasting non-antigen-specific NK cell effector function. The basic concepts derived from studying NK cell memory provide new insights about innate immunity and could lead to novel strategies to improve treatments for infectious diseases and cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26806484     DOI: 10.1038/nri.2015.9

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  93 in total

1.  T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

Authors:  Jacqueline G O'Leary; Mahmoud Goodarzi; Danielle L Drayton; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2006-04-16       Impact factor: 25.606

2.  Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Brian S Schwartz; Marcelo J Pando; Jessica Jarjoura; Vanessa A York; Jeffrey P Houchins; Steve Miller; Sang-Mo Kang; Phillip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

3.  Epicutaneous immunization with hapten-conjugated protein antigen alleviates contact sensitivity mediated by three different types of effector cells.

Authors:  Monika Majewska-Szczepanik; Anna Strzępa; Iwona Drożyńska; Sylwia Motyl; Tomasz Banach; Marian Szczepanik
Journal:  Pharmacol Rep       Date:  2012       Impact factor: 3.024

4.  Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-α, interferon-γ and interleukin-12.

Authors:  Monika Majewska-Szczepanik; Silke Paust; Ulrich H von Andrian; Philip W Askenase; Marian Szczepanik
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

Review 5.  Immunological memory within the innate immune system.

Authors:  Joseph C Sun; Sophie Ugolini; Eric Vivier
Journal:  EMBO J       Date:  2014-03-27       Impact factor: 11.598

6.  IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.

Authors:  Alexander Rölle; Julia Pollmann; Eva-Maria Ewen; Vu Thuy Khanh Le; Anne Halenius; Hartmut Hengel; Adelheid Cerwenka
Journal:  J Clin Invest       Date:  2014-11-10       Impact factor: 14.808

7.  Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation.

Authors:  Molly P Keppel; Liping Yang; Megan A Cooper
Journal:  J Immunol       Date:  2013-03-25       Impact factor: 5.422

8.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

Authors:  Mónica Gumá; Ana Angulo; Carlos Vilches; Natalia Gómez-Lozano; Núria Malats; Miguel López-Botet
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

9.  Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

Authors:  Silke Paust; Harvinder S Gill; Bao-Zhong Wang; Michael P Flynn; E Ashley Moseman; Balimkiz Senman; Marian Szczepanik; Amalio Telenti; Philip W Askenase; Richard W Compans; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2010-10-24       Impact factor: 25.606

10.  The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.

Authors:  Magdalena Paolino; Axel Choidas; Stephanie Wallner; Blanka Pranjic; Iris Uribesalgo; Stefanie Loeser; Amanda M Jamieson; Wallace Y Langdon; Fumiyo Ikeda; Juan Pablo Fededa; Shane J Cronin; Roberto Nitsch; Carsten Schultz-Fademrecht; Jan Eickhoff; Sascha Menninger; Anke Unger; Robert Torka; Thomas Gruber; Reinhard Hinterleitner; Gottfried Baier; Dominik Wolf; Axel Ullrich; Bert M Klebl; Josef M Penninger
Journal:  Nature       Date:  2014-02-19       Impact factor: 49.962

View more
  209 in total

1.  The Activating C-type Lectin-like Receptor NKp65 Signals through a Hemi-immunoreceptor Tyrosine-based Activation Motif (hemITAM) and Spleen Tyrosine Kinase (Syk).

Authors:  Björn Bauer; Tanja Wotapek; Tobias Zöller; Emilia Rutkowski; Alexander Steinle
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

2.  CD8+ T Cells and NK Cells: Parallel and Complementary Soldiers of Immunotherapy.

Authors:  Jillian Rosenberg; Jun Huang
Journal:  Curr Opin Chem Eng       Date:  2017-12-14       Impact factor: 5.163

3.  Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and NK Cell Function.

Authors:  Helen R Wagstaffe; Harry Pickering; Joanna Houghton; Jason P Mooney; Asia-Sophia Wolf; Natalie Prevatt; Ron H Behrens; Martin J Holland; Eleanor M Riley; Martin R Goodier
Journal:  J Immunol       Date:  2019-08-19       Impact factor: 5.422

4.  Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells.

Authors:  Francesco Marras; Anna Casabianca; Federica Bozzano; Maria Libera Ascierto; Chiara Orlandi; Antonio Di Biagio; Emanuele Pontali; Chiara Dentone; Giancarlo Orofino; Laura Nicolini; Lucia Taramasso; Mauro Magnani; Francesco M Marincola; Ena Wang; Lorenzo Moretta; Andrea De Maria
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

5.  Natural killer cells are pivotal for in vivo protection following systemic infection by Sporothrix schenckii.

Authors:  Lucas Souza Ferreira; Deivys Leandro Portuondo; Marisa Campos Polesi; Iracilda Zeppone Carlos
Journal:  Immunology       Date:  2018-08-14       Impact factor: 7.397

Review 6.  CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.

Authors:  Joseph D Malaer; Porunelloor A Mathew
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

Review 7.  Innate Lymphoid Cell Immunometabolism.

Authors:  Timothy E O'Sullivan; Joseph C Sun
Journal:  J Mol Biol       Date:  2017-09-01       Impact factor: 5.469

Review 8.  Immune regulatory cell infusion for graft-versus-host disease prevention and therapy.

Authors:  Bruce R Blazar; Kelli P A MacDonald; Geoffrey R Hill
Journal:  Blood       Date:  2018-05-04       Impact factor: 22.113

9.  Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4+ T cell help.

Authors:  Jing Ni; Oliver Hölsken; Matthias Miller; Quirin Hammer; Merlin Luetke-Eversloh; Chiara Romagnani; Adelheid Cerwenka
Journal:  Oncoimmunology       Date:  2016-08-05       Impact factor: 8.110

10.  Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8+ T cells.

Authors:  Keunok Jung; Ji-Hee Ha; Jung-Eun Kim; Jeong-Ah Kim; Ye-Jin Kim; Chul-Ho Kim; Yong-Sung Kim
Journal:  Oncoimmunology       Date:  2018-03-06       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.